Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Broncus HoldingBRNHF 43 Days Payable is 46.95 as of Dec. 2025, which is 25% below its 10-year median of 62.78. GuruFocus rates BRNHF with a GF Score™ of 43/100. The stock has 7 warning signs investors should review. Among 794 Medical Devices & Instruments companies, Broncus Holding ranks worse than 52.64% on this metric.
The historical data trend for Broncus Holding's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Broncus Holding's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Broncus Holding Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Broncus Holding's Days Payable distribution charts can be found below:
* The bar in red indicates where Broncus Holding's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Broncus Holding's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Broncus Holding (BRNHF) has a Days Payable of 46.95 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Broncus Holding and its competitors. This is 25% below median its historical median of 62.78. Over the past decade, Broncus Holding's Days Payable has ranged from 42.88 to 146.54. According to the industry distribution chart, Broncus Holding ranks #418 out of 794 companies in the Medical Devices & Instruments industry, placing it in the top 52.6%.
Is Broncus Holding's Days Payable too high?
Broncus Holding's current Days Payable of 46.95 is 25% below median its 10-year median of 62.78. Over the past 10 years, this metric has ranged from a low of 42.88 to a high of 146.54. The Medical Devices & Instruments industry median Days Payable is 67.97. Broncus Holding's value of 46.95 is 30.9% below this industry median. Based on the distribution chart, Broncus Holding ranks #418 out of 794 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Broncus Holding has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does Broncus Holding's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Broncus Holding ranks #418 out of 794 companies for Days Payable. This places Broncus Holding in the lower half of its industry. The industry median Days Payable is 67.97. Broncus Holding's value of 46.95 is 30.9% below this benchmark. Historically, Broncus Holding's own Days Payable has ranged from 42.88 to 146.54 over the past decade. While the company's 10-year median is 62.78 vs. the industry median of 67.97, Broncus Holding has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.97, based on 794 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Broncus Holding's current Days Payable of 46.95 is 30.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Broncus Holding and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Broncus Holding's current Days Payable is 46.95, which is 25% below median its own 10-year median of 62.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Broncus Holding stock overvalued right now?
Broncus Holding (BRNHF) has a current Days Payable of 46.95. The current Days Payable is 46.95, which is 25% below median its 10-year median of 62.78 and 30.9% below the Medical Devices & Instruments industry median of 67.97. Broncus Holding's overall GF Score™ is 43/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Broncus Holding (BRNHF), the current Days Payable is 46.95 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Broncus Holding Corp is focused on provision of interventional treatment of Chronic Obstructive Pulmonary Disease and lung cancer. It engages in the field of Interventional Pulmonology, providing solutions for lung diseases in China and globally. Its products portfolio includes the InterVapor Thermal Vapor Treatment System the only implantable medical device to treat COPD; BroncAblate Radiofrequency Ablation System the transbronchial interventional treatment product for lung cancer; Targeted Lung Denervation Radiofrequency Ablation System the self-developed targeted radiofrequency ablation system in China to reduce the risk of acute exacerbation of COPD. Geographically, the company operates in Chinese Mainland; European Union; and Other Regions.
43GF Score
Get the complete analysis for BRNHF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BRNHF has been successfully added to your 
